IMR Press / CEOG / Volume 43 / Issue 3 / DOI: 10.12891/ceog3103.2016

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Umbilical arterial N-terminal pro-B-type natriuretic peptide levels in preeclampsia, fetal growth restriction, preterm birth and fetal distress
Show Less
1 Department of Obstetrics and Gynecology, Daegu Catholic University Hospital, Daegu
2 Department of Obstetrics and Gynecology, Kyungpook National University Hospital, Daegu (Republic of Korea)
Clin. Exp. Obstet. Gynecol. 2016, 43(3), 393–396; https://doi.org/10.12891/ceog3103.2016
Published: 10 June 2016
Abstract

Objective: To evaluate fetal cardiopulmonary stress in pregnancies complicated by preeclampsia (PE), fetal growth restriction (FGR), preterm birth (PT), and fetal distress (FD) using umbilical arterial blood N-terminal pro-B-type natriuretic peptide (NT-proBNP). Materials and Methods: The study included 146 blood samples that were drawn from umbilical arteries at the time of delivery (20 cases of PE, 11 cases of FGR, 31 cases of PT, 23 cases of FD, and 61 cases of gestational age-matched controls) and analyzed. The main outcome measures included neonatal birthweight, cord pH, and umbilical arterial NT-proBNP. Results: The umbilical arterial NT-proBNP levels were significantly higher in the PE, FGR, PT, and FD groups than in the control group. The umbilical arterial NT-proBNP levels were negatively correlated with gestational age, birthweight, and umbilical arterial pH. Conclusions: Umbilical arterial NT-proBNP levels are elevated in stressful fetal conditions and have the potential to be considered as a marker for fetal cardiopulmonary stress.
Keywords
Cardiopulmonary state
Fetal stress
NT-proBNP
Marker
Umbilical artery
Share
Back to top